Variant report
Variant | rs10169159 |
---|---|
Chromosome Location | chr2:113030609-113030610 |
allele | G/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:39)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:39 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | RCOR1 | chr2:113030281-113030747 | K562 | blood: | n/a | n/a |
2 | ARID3A | chr2:113030045-113030666 | K562 | blood: | n/a | n/a |
3 | JUND | chr2:113029639-113031158 | K562 | blood: | n/a | n/a |
4 | CUX1 | chr2:113030202-113030856 | K562 | blood: | n/a | n/a |
5 | GATA2 | chr2:113030321-113030645 | K562 | blood: | n/a | n/a |
6 | CEBPD | chr2:113030134-113030770 | K562 | blood: | n/a | n/a |
7 | TEAD4 | chr2:113030107-113030833 | K562 | blood: | n/a | n/a |
8 | RCOR1 | chr2:113030359-113030862 | K562 | blood: | n/a | n/a |
9 | UBTF | chr2:113030334-113030835 | K562 | blood: | n/a | n/a |
10 | TBP | chr2:113030237-113030761 | K562 | blood: | n/a | n/a |
11 | CEBPD | chr2:113030135-113030715 | K562 | blood: | n/a | n/a |
12 | TBL1XR1 | chr2:113030047-113030862 | K562 | blood: | n/a | n/a |
13 | ZMIZ1 | chr2:113030257-113031034 | K562 | blood: | n/a | n/a |
14 | CCNT2 | chr2:113030275-113030910 | K562 | blood: | n/a | n/a |
15 | POLR2A | chr2:113030293-113030807 | K562 | blood: | n/a | n/a |
16 | MYC | chr2:113030292-113030736 | K562 | blood: | n/a | n/a |
17 | ZNF384 | chr2:113030208-113034002 | K562 | blood: | n/a | n/a |
18 | PML | chr2:113030155-113030672 | K562 | blood: | n/a | n/a |
19 | GATA1 | chr2:113029747-113031594 | K562 | blood: | n/a | n/a |
20 | UBTF | chr2:113030451-113031175 | K562 | blood: | n/a | n/a |
21 | TAL1 | chr2:113030265-113030657 | K562 | blood: | n/a | n/a |
22 | TEAD4 | chr2:113030222-113030709 | K562 | blood: | n/a | n/a |
23 | POLR2A | chr2:113030266-113030837 | K562 | blood: | n/a | n/a |
24 | MXI1 | chr2:113030449-113030723 | K562 | blood: | n/a | n/a |
25 | IRF1 | chr2:113029973-113031927 | K562 | blood: | n/a | n/a |
26 | POLR2A | chr2:113030196-113032194 | K562 | blood: | n/a | n/a |
27 | MAFF | chr2:113030257-113030610 | K562 | blood: | n/a | n/a |
28 | GATA2 | chr2:113030202-113030654 | K562 | blood: | n/a | n/a |
29 | IRF1 | chr2:113030256-113032085 | K562 | blood: | n/a | n/a |
30 | POLR2A | chr2:113030258-113030731 | K562 | blood: | n/a | n/a |
31 | EP300 | chr2:113030096-113030770 | K562 | blood: | n/a | n/a |
32 | ATF1 | chr2:113030281-113030684 | K562 | blood: | n/a | n/a |
33 | BHLHE40 | chr2:113030326-113030610 | K562 | blood: | n/a | n/a |
34 | MAFK | chr2:113030223-113030643 | K562 | blood: | n/a | n/a |
35 | NR2F2 | chr2:113030194-113030657 | K562 | blood: | n/a | n/a |
36 | ZBTB7A | chr2:113030568-113030781 | K562 | blood: | n/a | n/a |
37 | GATA1 | chr2:113030158-113031322 | PBDE | blood: | n/a | n/a |
38 | POLR2A | chr2:113030190-113030714 | K562 | blood: | n/a | n/a |
39 | MAZ | chr2:113030163-113031058 | K562 | blood: | n/a | n/a |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ZC3H6 | TF binding region |
ENSG00000238951 | TF binding region |
ENSG00000033170 | Chromatin interaction |
ENSG00000144161 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs10167090 | 0.82[AFR][1000 genomes];0.83[ASN][1000 genomes] |
rs10175234 | 0.91[ASN][1000 genomes] |
rs10177573 | 0.97[AFR][1000 genomes];0.96[ASN][1000 genomes] |
rs10183121 | 0.88[ASN][1000 genomes] |
rs10191002 | 0.81[AFR][1000 genomes] |
rs10196933 | 0.81[ASN][1000 genomes] |
rs10203614 | 0.81[ASN][1000 genomes] |
rs10203843 | 0.92[AFR][1000 genomes];0.81[ASN][1000 genomes] |
rs10205038 | 0.94[ASN][1000 genomes] |
rs10439391 | 0.81[ASN][1000 genomes] |
rs10864903 | 0.93[AFR][1000 genomes];0.81[ASN][1000 genomes] |
rs11123131 | 0.82[ASN][1000 genomes] |
rs11123132 | 0.83[ASN][1000 genomes] |
rs11123135 | 0.81[ASN][1000 genomes] |
rs11123136 | 0.82[AFR][1000 genomes] |
rs11674953 | 0.92[ASN][1000 genomes] |
rs11688418 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs11689487 | 0.99[ASN][1000 genomes] |
rs11691431 | 0.94[ASN][1000 genomes] |
rs11691794 | 0.99[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];0.99[ASN][1000 genomes] |
rs11896500 | 0.92[AFR][1000 genomes] |
rs11903741 | 0.92[AFR][1000 genomes] |
rs11904424 | 0.90[AFR][1000 genomes] |
rs12464478 | 0.84[AFR][1000 genomes] |
rs12620553 | 0.81[ASN][1000 genomes] |
rs12711737 | 0.93[ASN][1000 genomes] |
rs12711738 | 0.93[AFR][1000 genomes];0.99[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs13387611 | 0.82[AFR][1000 genomes] |
rs13407329 | 0.82[ASN][1000 genomes] |
rs34471791 | 0.82[AFR][1000 genomes] |
rs34623958 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs4258804 | 0.88[AFR][1000 genomes];0.81[ASN][1000 genomes] |
rs4332934 | 0.95[AFR][1000 genomes];0.81[ASN][1000 genomes] |
rs4392265 | 0.96[ASN][1000 genomes] |
rs4399734 | 0.87[AFR][1000 genomes] |
rs4419238 | 0.81[ASN][1000 genomes] |
rs4430968 | 0.95[AFR][1000 genomes];0.81[ASN][1000 genomes] |
rs4446076 | 0.96[ASN][1000 genomes] |
rs4450606 | 0.95[AFR][1000 genomes];0.81[ASN][1000 genomes] |
rs4450607 | 0.84[AFR][1000 genomes] |
rs4456711 | 0.92[AFR][1000 genomes];0.81[ASN][1000 genomes] |
rs4507112 | 0.82[AFR][1000 genomes] |
rs4522611 | 0.87[AFR][1000 genomes] |
rs4525706 | 0.82[AFR][1000 genomes] |
rs4539797 | 0.95[AFR][1000 genomes];0.81[ASN][1000 genomes] |
rs4542853 | 0.81[ASN][1000 genomes] |
rs4622729 | 0.87[AFR][1000 genomes] |
rs4849056 | 0.87[ASN][1000 genomes] |
rs4849057 | 0.92[ASN][1000 genomes] |
rs58337061 | 0.92[AFR][1000 genomes];0.81[ASN][1000 genomes] |
rs6542045 | 0.99[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs6542048 | 0.93[AFR][1000 genomes];0.98[AMR][1000 genomes];0.97[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs6542050 | 0.97[AFR][1000 genomes];0.96[ASN][1000 genomes] |
rs6542051 | 0.93[AFR][1000 genomes];0.81[ASN][1000 genomes] |
rs6542053 | 0.81[AFR][1000 genomes] |
rs6706874 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs6708164 | 0.87[AFR][1000 genomes] |
rs6716010 | 0.94[ASN][1000 genomes] |
rs6725933 | 0.81[ASN][1000 genomes] |
rs6733138 | 0.82[AFR][1000 genomes] |
rs6744364 | 0.82[AFR][1000 genomes] |
rs6745942 | 0.94[AFR][1000 genomes];0.96[ASN][1000 genomes] |
rs6751146 | 0.82[AFR][1000 genomes] |
rs6758110 | 0.82[AFR][1000 genomes] |
rs6761599 | 0.82[AFR][1000 genomes] |
rs71414636 | 0.87[ASN][1000 genomes] |
rs72831684 | 0.96[ASN][1000 genomes] |
rs7557281 | 0.95[AFR][1000 genomes];0.93[ASN][1000 genomes] |
rs7557862 | 0.82[AFR][1000 genomes] |
rs7564052 | 0.89[AFR][1000 genomes];0.81[ASN][1000 genomes] |
rs7569894 | 0.87[AFR][1000 genomes] |
rs7571435 | 0.92[ASN][1000 genomes] |
rs7591439 | 0.82[AFR][1000 genomes] |
rs7598168 | 0.84[AFR][1000 genomes] |
rs7599041 | 0.82[AFR][1000 genomes] |
rs7600338 | 0.81[ASN][1000 genomes] |
rs7601888 | 0.89[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv874863 | chr2:112591224-113157344 | Weak transcription Active TSS Strong transcription Flanking Active TSS Enhancers Genic enhancers Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 57 gene(s) | inside rSNPs | diseases |
2 | nsv874864 | chr2:112617280-113104142 | Strong transcription Enhancers Genic enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS Active TSS ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 57 gene(s) | inside rSNPs | diseases |
3 | nsv874865 | chr2:112623098-113049274 | Enhancers Genic enhancers Strong transcription Weak transcription ZNF genes & repeats Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 57 gene(s) | inside rSNPs | diseases |
4 | esv3422414 | chr2:112883450-113200285 | Strong transcription Weak transcription Bivalent Enhancer Enhancers ZNF genes & repeats Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 39 gene(s) | inside rSNPs | diseases |
5 | nsv582703 | chr2:112920219-113100014 | Weak transcription Flanking Active TSS Enhancers Active TSS Strong transcription ZNF genes & repeats Genic enhancers Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 37 gene(s) | inside rSNPs | diseases |
6 | nsv874867 | chr2:112930064-113038409 | Flanking Active TSS Enhancers Strong transcription Active TSS Weak transcription ZNF genes & repeats Genic enhancers Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 37 gene(s) | inside rSNPs | diseases |
7 | esv1805614 | chr2:112949713-113048705 | Enhancers Flanking Active TSS Weak transcription Strong transcription Active TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 36 gene(s) | inside rSNPs | diseases |
8 | nsv949573 | chr2:112986955-113320975 | Strong transcription Active TSS Enhancers Weak transcription Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 48 gene(s) | inside rSNPs | diseases |
9 | nsv874868 | chr2:113021811-113076095 | Enhancers Flanking Active TSS Weak transcription ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers Active TSS Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
10 | nsv874869 | chr2:113021811-113089267 | Flanking Active TSS Weak transcription Active TSS Strong transcription Transcr. at gene 5' and 3' Enhancers ZNF genes & repeats Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
11 | nsv874870 | chr2:113021811-113097699 | Enhancers Active TSS Flanking Active TSS Weak transcription Strong transcription ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
12 | nsv874871 | chr2:113021811-113217630 | Enhancers Weak transcription Active TSS Flanking Active TSS Strong transcription ZNF genes & repeats Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 34 gene(s) | inside rSNPs | diseases |
13 | nsv874872 | chr2:113027569-113070889 | Weak transcription Enhancers Strong transcription Transcr. at gene 5' and 3' Active TSS Flanking Active TSS ZNF genes & repeats Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
14 | nsv874873 | chr2:113027569-113083367 | Active TSS Weak transcription Flanking Active TSS Enhancers Strong transcription ZNF genes & repeats Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
15 | nsv874874 | chr2:113027569-113089267 | Active TSS Strong transcription Transcr. at gene 5' and 3' Weak transcription Enhancers Flanking Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Genic enhancers Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
No data |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:113025200-113032600 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr2:113026400-113032200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
3 | chr2:113026800-113032600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr2:113029200-113031200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
5 | chr2:113029400-113032200 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
6 | chr2:113030000-113031600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
7 | chr2:113030200-113031400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
8 | chr2:113030200-113031400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
9 | chr2:113030200-113032000 | Weak transcription | HepG2 | liver |
10 | chr2:113030400-113031400 | Flanking Active TSS | K562 | blood |
11 | chr2:113030600-113032200 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |